PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies-Reference-Cited by-同舟云学术

PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies

Published:2017-12-16 Issue:12 Volume:9 Page:172
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Perdrix Anne,Najem Ahmad,Saussez Sven,Awada Ahmad,Journe Fabrice,Ghanem Ghanem,Krayem Mohammad

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

http://www.mdpi.com/2072-6694/9/12/172/pdf

Reference75 articles.

1. TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

2. Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

3. Wild type p53 reactivation: From lab bench to clinic

4. Therapeutic targeting of p53 by small molecules

5. CRISPR-Cas9–based target validation for p53-reactivating model compounds

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutant P53 modulation by cryptolepine through cell cycle arrest and apoptosis in triple negative breast cancer;Biomedicine & Pharmacotherapy;2024-10

2. Targeting apoptotic pathways for cancer therapy;Journal of Clinical Investigation;2024-07-15

3. Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer;Cancer Medicine;2024-07

4. Targeting Hdm2 and Hdm4 in Anticancer Drug Discovery: Implications for Checkpoint Inhibitor Immunotherapy;Cells;2024-06-29

5. The Antioxidant Potential and Anticancer Activity of Halodule uninervis Ethanolic Extract against Triple-Negative Breast Cancer Cells;Antioxidants;2024-06-14